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で感度  70～80%,  特異度 94～99%（肺炎球菌のほとんどの血清型を検出可能）










レジオネラ症では、症状の出現 2－3 日後より尿中に抗原が出現し、2 週間程
度抗原陽性が持続する。肺炎球菌と同様に ICT で検出する方法であり簡便であ
る。従来は血清抗体価のみの診断であり、尿中抗原検出により診断率が格段に
向上した。注意点は、Legionella pneumophila serogroup 1 のみしか検出できない































































Rapid and accurate detection of resistant bacteria for respiratory tract infection 
 
We evaluated the combined use of real-time and multiplex PCR to which we 
referred as RQ-mPCR (real-time quantitative PCR combined with multiplex PCR) assay, 
using 200 clinical strains and 200 purulent sputum samples. The data indicate our 
RQ-mPCR method can rapidly and accurately quantify S. pneumoniae and 
simultaneously detect drug resistance genes in sputum samples. We employed a lytA 
primer/probe set for real-time PCR and simultaneously performed multiplex PCR for 
altered pbp1a, pbp2x, and pbp2b genes and for mef(A) and erm(B) macrolide resistance 
genes. The sensitivity and specificity of the assay in sputum samples relative to isolated 
S. pneumoniae was 100% and 99.3% for lytA, 100% and 93.9% for erm(B), 100% and 
94.8% for mef(A), 94.4% and 97.5% for pbp1a, 100% and 94.1% for pbp2x, and 100% 
and 95.6% for pbp2b. 
 
We also established the rapid quantitative detection of 
metallo-beta-lactamase-producing P. aeruginosa in clinical isolates and samples using 
real-time PCR targeting gyrB (identification of P. aeruginosa) and blaIMP 
(identification of metallo-beta-lactamase). With clinical isolates, it was demonstrated 
that gyrB-PCR had a linear quantitative detection range of 7 logs with a lower detection 
limit of 103 copies per reaction. The relative sensitivities and specificities of this 
real-time PCR assay were as follows: 100.0% and 100.0% for clinical isolates, 100.0% 
and 98.4% for clinical specimens, respectively. 
The present PCR assay was thus easily and quickly performed, and accurately detected 
Pseudomonas aeruginosa and metallo-beta-lactamase, and it should be helpful in the 
diagnosis and control of nosocomial infection. 
We expect that the genetic diagnosis will be an adjunct to, or a replacement of, 
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Rapid and accurate detection of resistant bacteria for respiratory tract infection 
-Present situation and future- 
 
Respiratory tract infection (RTI) is a common and potentially life-threatening illness 
that continues to be a major medical problem. The rapid detection system such as Gram 
staining or urinary antigen detection for respiratory infection is useful. However, the 
genetic diagnosis for resistant pathogens has been expected because they have been 
prevalent.  
We evaluated the RQ-mPCR (real-time quantitative PCR combined with multiplex 
PCR) assay for drug-resistant S. pneumonia infection. The RQ-mPCR method 
developed here had high sensitivity and specificity for pneumococci and could detect 
drug resistance in both clinical S. pneumoniae strains and in sputum samples. 
Furthermore, the results can be obtained directly from clinical samples within 3 h. This 
method may be helpful for the rapid screening of resistance in pneumococcal isolates, 
and should allow the administration of earlier, more focused and effective treatment of 
drug-resistant S. pneumonia. 
We also established the rapid quantitative detection of 
metallo-beta-lactamase-producing P. aeruginosa in clinical isolates and samples using 
real-time PCR targeting gyrB (identification of P. aeruginosa) and blaIMP 
(identification of metallo-beta-lactamase). The present PCR assay was thus easily and 
quickly performed, and accurately detected Pseudomonas aeruginosa and 
metallo-beta-lactamase, and it should be helpful in the diagnosis and control of 
nosocomial infection. 
We expect that the genetic diagnosis will be an adjunct to, or a replacement of, 
conventional culture methods and susceptibility tests. 
 
 
Table 1 Causative agents from CAP in Japan
report Saito A, et al. Miyashita N, et al. Ishida T, et al.
J I f t Ch th 12 63 J M d Mi bi l 54 395 J I f t Ch th 10 359source  n ec  emo er : ,  e  cro o : ,  n ec  emo er : ,
published year 2006 2005 2004
in/out patient inpatient inpatient inpatient
total number of cases 232 372 350
S. pneumoniae 24.6 30.1 53.5
H. influenzae 18.5 16.7 8.3
M. pneumoniae 5.2 12.4 15.4
C. pneumoniae 6.5 9.0 4.7
Legionella spp. 3.9 1.7 2.0
S. aureus 3.4 4.3 2.0
C itt i 2 2 1 3 0 4. ps as . . .
Moraxella spp. 2.2 4.7 2.4
Klebsiella spp. 1.3 2.7 2.0
S milleri group 1 3 2 0 1 6. . . .
Anaerobe 2.5 7.4 1.6
Coxiella spp. 0.9 0.7
P. aeruginosa 0.4 2.7 1.6 
Fungus 0.4 0.4
Virus 22.4 3.3 2.4
others 2.8 1.0 3.5
(%)
Unknown 23.7 33.6 33.1
Table  2 Clinical usefulness of sputum Gram stain for pneumococcal and Haemophilus
influenzae pneumonia in 533 patients with community-acquired pneumonia that required 
hospitalization.
Rosón B et al Prospective Study of the Usefulness of sputum gram stain in the initial approach to community,  .               -
acquired pneumonia requiring hospitalization. Clinical infectious disease 2000:31:869-874.
Table 3 Evaluation of a rapid immunochromatographic test for detection of 
Streptococcus pneumoniae antigen in urine samples
R f iti it ifi ite erences sens v y spec c y
B l DR l 74 % 94 %ou ware . et a .J Infect 55:300–9, 2007.
Smith M. D. et al.
J Clin Microbiol. 41:2810-2813, 2003. 82 % 97 %
77.7 % 98.8 %Farina C. et al.New Microbiol. 25: 259-263, 2002.
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Fig. 3 Prevalence of β-lactamase negative ampicillin resistant Haemophilus influenzae
(BLNAR) in Nagasaki Univ. Hospital
200 clinical strains and 200 sputum
culture and MIC testsRQ-mPCR
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Fig. 4 Methods in comparison with classical techniques.
(Rapid Identification of Penicillin and Macrolide Resistance Genes and Simultaneous Quantification of Streptococcus pneumoniae Using a Novel 
Real-time Multiplex PCR Assay)
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Fig. 5 PCR results and MICs of penicillin G and erythromycin in 200 pneumococcal isolates
Type 1: non- metallo-β-lactamase-
producing P. aeruginosa. 
Type 2: metallo-β-lactamase-
producing P. aeruginosa. 
Type 3: metallo-β-lactamase-
producing non-P. aeruginosa. 
Type 4: non-metallo-β-lactamase-
producing non-P. aeruginosa.   
Fig.6 Melting peak patterns for P. aeruginosa and metallo-β-lactamase. Types 1-4 were classified based on combinations of the two 
melting peak patterns. The black line indicates 88℃, and the red dotted line indicates 85℃.  
